Composite frame system
    1.
    发明授权

    公开(公告)号:US10828121B2

    公开(公告)日:2020-11-10

    申请号:US16282403

    申请日:2019-02-22

    IPC分类号: F16M11/00 A61B50/10 F16M1/00

    摘要: The present disclosure describes composite frame systems. The internal composite frame system may include at least one composite frame component including an intermediate frame element having a first side and a second side. A first plate may be positioned on the first side, and a second plate may be positioned on the second side. One or more fastener assemblies are operable to couple the first and second plates to the intermediate frame element.

    SYSTEMS AND METHODS FOR INTRAOCULAR LENS SELECTION

    公开(公告)号:US20200015894A1

    公开(公告)日:2020-01-16

    申请号:US16171515

    申请日:2018-10-26

    IPC分类号: A61B34/10 G06T7/73 G06T7/00

    摘要: Systems and methods for intraocular lens selection include receiving, by one or more computing devices implementing a prediction engine, pre-operative multi-dimensional images of an eye; extracting, by the prediction engine, pre-operative measurements of the eye based on the pre-operative images; estimating, by the prediction engine using a prediction model based on a machine learning strategy, a post-operative position of an intraocular lens based on the extracted pre-operative measurements; selecting a power of the intraocular lens based on the estimated post-operative position of the intraocular lens; and selecting the intraocular lens based on the selected power. In some embodiments, the systems and methods further include receiving post-operative multi-dimensional images of the eye after implantation of the selected intraocular lens, extracting post-operative measurements of the eye, and updating the prediction model based on the pre-operative measurements and the post-operative measurements.

    OPTIMIZED PNEUMATIC DRIVE LINES
    5.
    发明申请

    公开(公告)号:US20180200110A1

    公开(公告)日:2018-07-19

    申请号:US15922196

    申请日:2018-03-15

    IPC分类号: A61F9/007 A61B17/00 A61M25/00

    摘要: In one exemplary aspect, the present disclosure is directed to a system. The system includes a pneumatic surgical instrument and a surgical console operable to provide compressed gas to the pneumatic surgical instrument. Additionally, the system includes a pneumatic drive line coupling the pneumatic surgical instrument to the surgical console. The pneumatic drive line has an internal bore configured to deliver the compressed gas to the pneumatic surgical instrument. The internal bore has a non-uniform cross-section along a length of the pneumatic drive line.

    DEVICES AND METHODS FOR MULTISPOT SCANNING
    8.
    发明申请

    公开(公告)号:US20170172802A1

    公开(公告)日:2017-06-22

    申请号:US15453288

    申请日:2017-03-08

    IPC分类号: A61F9/008

    摘要: An ophthalmic endoprobe system comprises an optical fiber configured to transmit light energy along an optical axis. The system further comprises a first scanning element rotatable relative to the optical fiber and arranged to receive at least a portion of the transmitted light energy. The first scanning element includes a diffractive optical element. The system also comprises a second scanning element rotatable relative to the first scanning element and arranged to receive at least a portion of the transmitted light energy from the first scanning element.

    Infusion pressure control using blood pressure

    公开(公告)号:US09655776B2

    公开(公告)日:2017-05-23

    申请号:US14533266

    申请日:2014-11-05

    发明人: Steven T. Charles

    摘要: Methods, systems, and software for controlling infusion pressure, such as during a medical procedure, using systemic blood pressure are described. Systemic blood pressure, such as brachial arm blood pressure or radial artery blood pressure, may be used to estimate central retinal artery blood pressure to estimate critical closing pressure. Further, the disclosure relates to controlling infusion pressure to prevent an increase in intraocular pressure above the estimated critical closing pressure when such is not desired, and, when such is desired, using systemic blood pressure and infusion pressure to control an intentional increase in intraocular pressure above the estimated critical closing pressure to stop intraocular bleeding.